from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3070/-

LFCtreatmentdescriptionclass of inhibitor

-0.354

Amikacinug/mL Amikacintranslation

0.110

Cap5-10ug/mL Capreomycintranslation

1.386

Rox10-50 ug/mL Roxithromycintranslation

-0.578

SM2-5 ug/mL Streptomycintranslation

-0.066

Tet5-10 ug/mL Tetracyclinetranslation

0.457

Rif0.2-5ug/mL Rifampicintranscription

-0.528

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.288

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.971

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.078

CPZ10-50 ug/mL Chlorpromazinerespiration

0.128

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.556

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.506

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.830

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.192

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.319

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.171

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.633

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.336

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.725

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.546

KCN5-20 ug/mL Potassium cyaniderespiration

-0.205

NaN30.2-2 mM Sodium aziderespiration

0.423

Nigericin50 uM Nigericinrespiration

-0.139

TRC10-150 ug/mL Triclosanrespiration

1.858

TRZ10-25 ug/mL Thioridazinerespiration

1.404

Valinomycin0.5-10 uM Valinomycinrespiration

-0.030

ZnSO42 mM ZnSO4respiration

2.521

menadione6-10 ug/mL Menadionerespiration

-0.648

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.114

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.493

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.085

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.259

NRP_1Non-replicating persistence stage 1dosRassociated

-0.564

Amp0.2mg/mL AmpicillincellWall

-0.240

Cephalexin20-100 ug/mL CephalexincellWall

-0.500

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.335

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.062

EMB10-20 ug/mL EthambutolcellWall

-1.044

Eta12-40 ug/mL EthionamidecellWall

-1.365

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.882

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.141

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.020

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.443

BZA0.12 mg/mL BenzamidearomaticAmides

-0.422

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.499

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.158

H2O24 mM hydrogen peroxideDNAdamaging

-0.105

Levo10 ug/mL LevofloxacinDNAdamaging

-0.304

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.522

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.511

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.027

UVUV-irradiationDNAdamaging

3.428

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.323

Antimycin12.5-50 ug/mL Antimycin A?

0.015

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.600

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.705

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.465

PA8240.2-2 ug/mL PA-824?

0.001

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.233

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.087

Verapamil50 uM Verapamil?

-0.116

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.035

methoxatin10-20 ug/mL Methoxatin?